Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
acute hepatic porphyrias
akin akinc
alnylam pharmaceuticals
aminolevulinic acid
boston
boston blog main
boston top stories
clinical trials
drugs
fda
givosiran
life sciences
national blog main
onpattro
patisiran
paul matteis
rna interference
stifel financial
What
medicine
2
×
quick
2
×
ago
alnylam
approval
coronary
cycle
dangerous
data
dieting
diets
disease
drug
england
fda
gain
gaining
health
heart
indicated
ineffective
interference
journal
know
lead
looked
losing
loss
new
nod
people
pharmaceuticals
problems
published
raise
rapidly
researchers
risk
rna
rnai
Language
Current search:
quick
×
medicine
×
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
@theverge.com
7 years ago
Rapidly losing and gaining weight could be dangerous if you have heart disease
